Replies to post #55 on Atea Pharmaceuticals Inc (AVIR)

[DewDiligence]

In other words, AVIR could do better than $5.75/sh by simply liquidating.

[DewDiligence]

AVIR rejects Tang buyout offer, as expected:

https://www.globenewswire.com/news-release/2023/05/30/2678205/0/en/Atea-Pharmaceuticals%5B%E2%80%A6%5DTang-Capital-Partners-Affiliate-Concentra-Biosciences.html

The offer was for less than AVIR’s cash value.